Molecular Diagnostics
News on lab-developed tests and emerging diagnostic technologies.
360Dx Index Continues Growth in July, Increasing 5 Percent
Of the 29 companies in the index, 16 saw increases in their stock prices, while 13 saw declines.
Veracyte Aims to Broaden Reach of Decipher Prostate Assay as Studies Continue to Expand Utility
Premium
The company reported significant momentum in test volumes for the second quarter of this year as new publications shore up utility evidence and open new applications.
DiaSorin Q2 Revenues Rise 20 Percent on SARS-CoV-2 Testing Demand
DiaSorin posted Q2 molecular revenues of €69.4 million, up 23 percent year over year from €56.6 million.
Cepheid Gets $28M From BARDA for SARS-CoV-2 Tests
The funding is for the firm's SARS-CoV-2, pan-coronavirus, and multiplex SARS-CoV-2, influenza, and respiratory syncytial virus tests, according to BARDA.
Veracyte Q2 Revenues More Than Double on Test Volume Spike
The company's commercial test volume and test revenues were both up more than 200 percent compared to the same quarter last year.
Jul 29, 2021
Qiagen Q2 Revenues Grow 28 Percent
Jul 29, 2021
CareDx Q2 Revenues up 77 Percent
Jul 29, 2021
Cepheid Nabs CE Mark for PCR-Based HIV-1 Tests
Jul 29, 2021
Jul 28, 2021
Exact Sciences Q2 Revenues Rise 62 Percent
Jul 28, 2021
Strata Oncology Raises $90M in Series C Financing
Jul 27, 2021
Jul 22, 2021
Jul 22, 2021